Clinical Outcomes of Remdesivir in Moderate and Severe Cases of COVID-19: A Retrospective Cohort Study

Introduction: Remdesivir is a nucleotide analogue prodrug that perturbs viral replication. Remdesivir has been used in various trials previously for the treatment of Coronavirus Disease 2019 (COVID-19). Some clinical trials found that remdesivir had a mortality benefit, while other studies did not....

Full description

Bibliographic Details
Main Authors: Ruth Priya Senthiappan, Archana A Dambal, Mohan Kashinkunti, Kiran R Aithal, Rajendra Kumar Parakh, Bhargav Vuppumalla
Format: Article
Language:English
Published: JCDR Research and Publications Private Limited 2023-01-01
Series:Journal of Clinical and Diagnostic Research
Subjects:
Online Access:https://www.jcdr.net/articles/PDF/17403/61270_CE(Vi)_F(IS)_PF1(JY_KM_OM)_PFA(JY_KM)_PN(KM).pdf